145 related articles for article (PubMed ID: 17876153)
41. [A case report of un-resectable pancreas body carcinoma successfully treated by chemoradiotherapy].
Nagahama T; Ando M; Ohara T; Ganno H; Hataji K; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2425-7. PubMed ID: 20037444
[TBL] [Abstract][Full Text] [Related]
42. [A long-term survivor who received S-1-based multidisciplinary therapy for unresectable advanced pancreatic cancer].
Makino H; Kametaka H; Koyama T; Seike K
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2647-50. PubMed ID: 22189235
[TBL] [Abstract][Full Text] [Related]
43. [Intra-arterial cellular immunochemotherapy for unresectable pancreatic cancer with liver metastasis].
Horiuchi H; Toh U; Uchida S; Hayashi K; Kinoshita H; Yamana H; Aoyagi S; Shirouzu K; Koganemaru M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1752-4. PubMed ID: 15553704
[TBL] [Abstract][Full Text] [Related]
44. [A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy].
Matsukawa H; Shiozaki S; Takakura N; Aoki H; Fujiwara Y; Ohno S; Ojima Y; Harano M; Nishizaki M; Choda Y; Ninomiya M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2355-7. PubMed ID: 21224571
[TBL] [Abstract][Full Text] [Related]
45. [A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer].
Nakamoto Y; Ogata M; Yamamoto M
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1979-81. PubMed ID: 20948268
[TBL] [Abstract][Full Text] [Related]
46. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer.
Ke QH; Zhou SQ; Yang JY; Du W; Liang G; Lei Y; Luo F
World J Gastroenterol; 2014 Oct; 20(38):13987-92. PubMed ID: 25320537
[TBL] [Abstract][Full Text] [Related]
47. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma.
Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Takahashi S; Ohge H; Sueda T
Cancer Chemother Pharmacol; 2017 Apr; 79(4):775-781. PubMed ID: 28293715
[TBL] [Abstract][Full Text] [Related]
48. [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Sunagozaka H; Yamashita T; Kagaya T; Kato Y; Kaneko S
Gan To Kagaku Ryoho; 2006 Jun; 33(6):829-32. PubMed ID: 16770107
[TBL] [Abstract][Full Text] [Related]
49. [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
Hoshino H; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Eguchi H; Marubashi S; Tanemura M; Kitagawa T; Umeshita K; Monden M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2419-21. PubMed ID: 20037442
[TBL] [Abstract][Full Text] [Related]
50. [Adjuvant Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer following Gemcitabine and S-1 Chemotherapy--A Case Report].
Tono T; Kawasaki Y; Hashimoto M; Ikeda Y; Senba H; Okubo Y; Katayama T; Ishii T; Shinozaki K; Hayashi H; Yasuda S; Ohtsuru M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2373-5. PubMed ID: 26805368
[TBL] [Abstract][Full Text] [Related]
51. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine].
Kawasaki H; Kukita K; Mizushima Y; Hirata K
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1239-42. PubMed ID: 18633272
[TBL] [Abstract][Full Text] [Related]
52. [A case of locally advanced pancreatic cancer successfully resected after gemcitabine+S-1 therapy].
Moriyama M; Sawada S; Matsui K; Yoshioka I; Shibuya K; Osawa S; Yoshida T; Nagata T; Tsukada K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2187-9. PubMed ID: 25731465
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study.
Zhou J; Zhao R; Wen F; Zhang P; Tang R; Du Z; He X; Zhang J; Li Q
Med Oncol; 2015 Apr; 32(4):121. PubMed ID: 25788034
[TBL] [Abstract][Full Text] [Related]
54. [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
Funakoshi A; Senju T; Sumii T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1505-9. PubMed ID: 17033248
[TBL] [Abstract][Full Text] [Related]
55. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives].
Murakami Y; Uemura K; Sudo T
Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141
[No Abstract] [Full Text] [Related]
56. S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial.
Liao W; Huang J; Zhu G; Zhou J; Wen F; Zhang P; Zhou K; Wu Q; Wang X; Gou H; Li Q
Expert Rev Pharmacoecon Outcomes Res; 2020 Feb; 20(1):133-138. PubMed ID: 31597496
[No Abstract] [Full Text] [Related]
57. Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer.
Nakata B; Amano R; Nakao S; Tamura T; Shinto O; Hirakawa T; Okita Y; Yamada N; Hirakawa K
J Exp Clin Cancer Res; 2010 Feb; 29(1):15. PubMed ID: 20181235
[TBL] [Abstract][Full Text] [Related]
58. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
[TBL] [Abstract][Full Text] [Related]
59. TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).
Ioka T; Ueno M; Ueno H; Park JO; Chang HM; Sasahira N; Kanai M; Chung IJ; Ikeda M; Nakamori S; Mizuno N; Omuro Y; Yamaguchi T; Hara H; Sugimori K; Furuse J; Maguchi H; Furukawa M; Fukuzawa K; Kim JS; Yukisawa S; Takeuchi M; Okusaka T; Boku N; Hyodo I
Eur J Cancer; 2019 Jan; 106():78-88. PubMed ID: 30471651
[TBL] [Abstract][Full Text] [Related]
60. Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites.
Takahara N; Isayama H; Nakai Y; Ishigami H; Satoi S; Mizuno S; Kogure H; Matsubara S; Yamamoto N; Yamaguchi H; Tada M; Kitayama J; Watanabe T; Koike K
Invest New Drugs; 2016 Oct; 34(5):636-42. PubMed ID: 27339809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
